LONDON/SHANGHAI (Reuters) - China's largest vaccines company Zhifei will pay British drugmaker GSK 2.5 billion pounds ($3.05 billion) for the exclusive rights to distribute GSK's shingles vaccine in ...

LONDON, July 24 (Reuters) - A "shameful" corruption scandal in China will inevitably impact GlaxoSmithKline's business, the British drugmaker's chief executive said on Wednesday, adding he was ready ...

GSK plc GSK has reached an exclusive agreement with Chongqing Zhifei Biological Products, Ltd to co-promote GSK's shingles vaccine, Shingrix, in China for an initial three-year period with the ...

GSK plc GSK announced that it has revised its collaboration deal with Chongqing Zhifei Biological Products (Zhifei), China's largest vaccine maker, to co-market its shingles vaccine Shingrix in ...

LONDON/BEIJING, Dec 2 (Reuters) - GlaxoSmithKline's (GSK) chief executive is showing his commitment to doing business in China by joining a trade trip there, a GSK spokesman said on Monday, after ...

BEIJING — A British investigator and his Chinese American wife face trial in China on Friday after being swept up in a massive probe into possible corruption at British drugmaker GlaxoSmithKline.

GSK PLCGSK-1.13%decrease; red down pointing triangle extended its collaboration with Chongqing Zhifei Biological Products 300122-2.80%decrease; red down pointing triangle to commercialize its shingles ...

GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients; third IL-5 condition indication in the region. Phase 3 trial shows Nucala reduces COPD exacerbations; FDA ...

Chinese drug regulator has approved GSK's (NYSE:GSK) Nucala (mepolizumab) as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older. Nucala ...

GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated ...

Oct 9 (Reuters) - China's largest vaccines company Zhifei 300122.SZ will pay British drugmaker GSK GSK.L 2.5 billion pounds ($3.05 billion pound) for the exclusive rights to distribute GSK's shingles ...